Kordasiewicz Holly B.
EVP, Chief Development Officer
Kordasiewicz Holly B. has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
On the most recent filing, Kordasiewicz Holly B. is listed as EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC. Inside the rolling window, Kordasiewicz Holly B. reported no open-market purchases and 3 open-market sales totaling $4.8M in IONS. The largest disclosed transaction in the window is a sale of 60,846 IONS shares on Jun 12, 2026, worth $4.5M.
Companies traded
Other insiders at IONS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kordasiewicz Holly B. made?
Kordasiewicz Holly B. has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Kordasiewicz Holly B. trade?
Kordasiewicz Holly B. has filed SEC Form 4 disclosures for 1 company, including IONS.
When was Kordasiewicz Holly B.'s most recent SEC Form 4 filing?
Kordasiewicz Holly B.'s most recent SEC Form 4 filing on Tracefour is dated Jul 9, 2026.
What is Kordasiewicz Holly B.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kordasiewicz Holly B. is listed as EVP, Chief Development Officer.
What is Kordasiewicz Holly B.'s total buy and sell value in the current window?
Inside the rolling retention window, Kordasiewicz Holly B. bought $0 and sold $4.8M based on SEC Form 4 filings.
What was Kordasiewicz Holly B.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 60,846 IONS shares on 2026-06-12, worth $4.5M, per SEC Form 4 filings.